广州市妇女儿童医疗中心神经内科, 广东 广州 520120
朱海霞,硕士,副主任医师,研究方向:儿童神经病学,E-mail: 308768677@qq.com
收稿:2021-01-08,
纸质出版:2021-03-20
移动端阅览
朱海霞,李小晶,梁惠慈等.酪氨酸羟化酶缺乏症导致多巴反应性肌张力不全患儿临床及遗传特点[J].中山大学学报(医学科学版),2021,42(02):307-312.
ZHU Hai-xia,LI Xiao-jing,LIANG Hui-ci,et al.Clinical and Genetic Characteristics of Children with Dopa-Responsive Dystonia Due to Tyrosine Hydroxylase Deficiency[J].Journal of Sun Yat-sen University(Medical Sciences),2021,42(02):307-312.
朱海霞,李小晶,梁惠慈等.酪氨酸羟化酶缺乏症导致多巴反应性肌张力不全患儿临床及遗传特点[J].中山大学学报(医学科学版),2021,42(02):307-312. DOI:
ZHU Hai-xia,LI Xiao-jing,LIANG Hui-ci,et al.Clinical and Genetic Characteristics of Children with Dopa-Responsive Dystonia Due to Tyrosine Hydroxylase Deficiency[J].Journal of Sun Yat-sen University(Medical Sciences),2021,42(02):307-312. DOI:
目的
2
探讨酪氨酸羟化酶缺乏症(THD)导致多巴反应性肌张力不全患儿的临床、遗传特点、治疗和预后。
方法
2
回顾分析2017年6月至2020年11月神经内科住院部收治的6例THD导致多巴反应性肌张力不全患儿的临床资料及基因检测结果。
结果
2
6例患儿来自4个不同家庭,男4例,女2例,均患有肌张力障碍。中位发病年龄为11.5个月(3个月~4岁),6例患者发现
TH
基因复合杂合突变。
TH
基因共检测到7个突变,包括5个已知突变c.698G
>
A(p.R233H)、c.1145T
>
C(p.I382T)、c.739G
>
A(p.G247S)、c.1481C
>
T(p.T494M)、c.880G
>
C(p.G294R),以及2个新突变: c.1279A>G(p.Y427H)和 c.1128_1138del(p.Q377GfsTer12)。他们服用美多芭治疗,维持剂量为2~15 mg/(kg·d)。所有患者对美多芭反应良好,但病例4遗留有脊柱侧弯。
结论
2
THD临床表现多样,尽早识别和启动左旋多巴治疗,可明显改善预后。本研究检测到
TH
基因2个新的突变,错义突变c.1279A
>
G及移码突变c.1128_1138del。本研究拓宽了THD的基因型谱,为了解THD的分子机制提供了新思路。基因检测是THD最重要的诊断方法,对后续治疗及遗传咨询有指导意义。
Objective
2
To explore the clinical and genetic characteristics, treatment and prognosis of children with dopa-responsive dystonia due to tyrosine hydroxylase deficiency (THD).
Method
2
The clinical data of 6 children with dopa-responsive dystonia due to THD, who were admitted to the Department of Neurology of Guangzhou Women and Children’s Medical Center from June 2017 to Nov 2020, were retrospectively analyzed.
Results
2
These 6 children (4 boys and 2 girls), who came from four different families, suffered from dystonia. The median age of onset was 11.5 months (range from 3 months to 4 years). Compound heterozygous
TH
gene mutations were found in six patients. Seven different mutations were identified in the
TH
gene including five known mutations: c.698G
>
A(p.R233H), c.1145T
>
C(p.I382T), c.739G
>
A(p.G247S), c.1481C
>
T(p.T494M), c.880G
>
C(p.G294) and two novel mutations: c.1279A
>
G(p.Y427H) and c.1128_1138del(p.Q377GfsTer12). The patients took different doses of Madopa, ranging from 2 to 15 mg/(kg·d) in maintenance. All the patients responded well to Madopa but Case 4 was left with scoliosis.
Conclusions
2
THD can cause a broad range of clinical symptoms and severity. Early identification and initiation of levodopa therapy significantly improved the prognosis. We here identified two novel heterozygous variant in
TH
(c.1279A
>
G and c.1128_1138del). Our study expands the spectrum of genotype of THD in China, providing new insights into the molecular mechanism of THD. Genetic testing can make a definite diagnosis.
Segawa M , Hosaka A , Miyagawa F , et al . Hereditary progressive dystonia with marked diurnal fluctuation [J]. Adv Neurol , 1976 , 14 : 215 - 233 .
Zirn B , Steinberger D , Troidl C , et al . Frequency of GCH1 deletions in Dopa-responsive dystonia [J]. J Neurol Neurosurg Psychiatry , 2008 , 79 ( 2 ): 183 - 186 .
Clot F , Grabli D , Cazeneuve C , et al . Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia [J]. Brain , 2009 , 132 (Pt 7 ): 1753 - 1763 .
Lee WW , Jeon BS . Clinical spectrum of dopa-responsive dystonia and related disorders [J]. Curr Neurol Neurosci Rep , 2014 , 14 ( 7 ): 461 .
Furukawa Y , Lang AE , Trugman JM , et al . Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia [J]. Neurology , 1998 , 50 ( 4 ): 1015 - 1020 .
Willemsen MA , Verbeek MM , Kamsteeg EJ , et al . Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis [J]. Brain , 2010 , 133 ( Pt 6 ): 1810 - 1822 .
Dong HY , Feng JY , Yue XJ , et al . Dopa-responsive dystonia caused by tyrosine hydroxylase deficiency: Three cases report and literature review [J]. Medicine (Baltimore) , 2020 , 99 ( 33 ): e21753 .
Katus LE , Frucht SJ . An unusual presentation of tyrosinehydroxylase deficiency [J]. J Clin Mov Disord , 2017 , 4 : 18 . doi: 10.1186/s40734-017-0065-z http://dx.doi.org/10.1186/s40734-017-0065-z .
张尧 , 李东晓 , 刘怡 , 等 . 酪氨酸羟化酶缺乏症所致多巴反应性肌张力不全5例患儿临床及基因研究 [J]. 中华实用儿科临床杂志 , 2018 , 33 ( 6 ): 462 - 464 .
Zhang Y , Li DX , Liu Y , et al . Clinical and genetic study on 5 children with dopa-responsive dystonia due to tyrosine hydroxylase deficiency [J]. Chin J Appl Clin Pediatr , 2018 , 33 ( 6 ): 462 - 464 .
van den Heuvel LP , Luiten B , Smeitink JA , et al . A common point mutation in the tyrosine hydroxylase gene in autosomal recessive L-DOPA-responsive dystonia in the Dutch population [J]. Hum Genet , 1998 , 102 ( 6 ): 644 - 646 .
Zhang W , Zhou Z , Li X , et al . Dopa-responsive dystonia in Chinese patients: Including a novel heterozygous mutation in the GCH1 gene with an intermediate phenotype and one case of prenatal diagnosis [J]. Neurosci Lett , 2017 , 644 : 48 - 54 .
代丽芳 , 丁昌红 , 方方 . 多巴反应性肌张力障碍诊治进展 [J]. 中国循证儿科杂志 , 2019 , 14 ( 5 ): 395 - 400 .
Dai LF , Ding CH , Fang F . Progress in the diagnosis and treatment of dopa-responsive dystonia [J]. Chin J Evidence-based Pediatr , 2019 , 14 ( 5 ): 395 - 400 .
Couto CM , Vargas AP , Dos Santos Coimbra F , et al . A severe L-Dopa responsive dystonia with slow and continuous improvement in a patient with a novel mutation in the tyrosine hydroxylase gene [J]. Mov Disord Clin Pract , 2019 , 6 ( 6 ): 486 - 487 .
段丽芬 , 王惠萍 , 孙莹 , 等 . 酪氨酸羟化酶基因新突变导致多巴反应性肌张力障碍家系分析酪氨酸羟化酶基因新突变导致多巴反应性肌张力障碍家系分析 [J]. 中山大学学报(医学科学版) , 2019 , 40 ( 4 ): 598 - 603 .
Duan LF , Wang HP , Sun Y , et al . Analysis of a pedigree with dopa-responsive dystonia caused by novel mutation of TH gene [J]. J Sun Yat-sen Univ (Med Sci) , 2019 , 40 ( 4 ): 598 - 603 .
0
浏览量
611
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621
